Connor M Forbes

7PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersNephrology and urologyMedical molecular engineering of nucleic acids and proteinsLiquid biopsiesCentral and Eastern European languages (incl. Russian)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 26, 2025
FGF12 Enhances Prostate Cancer Cell Survival via the YB1-lncRNA Axis.

Zechao Huang, Sonia H Y Kung, Hans Adomat

|Sep 10, 2024
Break Wave Lithotripsy for Urolithiasis: Results of the First-in-Human International Multi-Institutional Clinical Trial.

Ben H Chew, Jonathan D Harper, Roger L Sur

|Jan 03, 2024
Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance.

Renjie Jin, Connor M Forbes, Nicole L Miller

|Jul 13, 2022
Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5-alpha reductase inhibitor treated human benign prostate hyperplasia patients.

Renjie Jin, Connor Forbes, Nicole L Miller

|Jun 14, 2022
Decision-making and improvements in health-related quality of life in patients with kidney stones: comparing surgery versus observation using a mixed methods analysis.

Connor M Forbes, Kemberlee Bonnet, Tracy Bryant

|Jul 21, 2021
The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.

RenJie Jin, Douglas W Strand, Connor M Forbes

Pageof 2

Frequent Collaborators

3 joint publications

Nicole L Miller

3 joint publications

Douglas W Strand

3 joint publications

Thomas Case

3 joint publications

Robert J Matusik